Fujian Cancer Hospital
Clinical trials sponsored by Fujian Cancer Hospital, explained in plain language.
-
New combo therapy aims to stop lung cancer spread after surgery
Disease control Recruiting nowThis study tests whether adding radiotherapy to standard immunotherapy after surgery can help control non-small cell lung cancer that has spread to multiple lymph nodes. About 60 adults aged 18-75 with high-risk stage III N2 lung cancer will receive either immunotherapy alone or …
Phase: PHASE4 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
New combo therapy aims to slow advanced breast cancer in organ-spread patients
Disease control Recruiting nowThis study tests whether adding a chemotherapy drug (capecitabine) to a standard treatment (dalpiciclib plus hormone therapy) can help control advanced breast cancer that has spread to organs like the liver or lungs. About 258 women with HR+/HER2- breast cancer will be randomly a…
Phase: PHASE3 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC